Global Infectious Disease Molecular Diagnostics Market Analysis By Product(Instruments (Benchtop instruments, Portable instruments), Reagents & Kits, Services, Others), By Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others), By Application(Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Infectious Diseases), By End-User(Hospitals, Clinics and Outpatient Diagnostic Centres, Diagnostic Laboratories, Research Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Oct 2025
- Report ID: 163576
- Number of Pages: 393
- Format:
-
keyboard_arrow_up
-
-
- F. Hoffmann‑La Roche Ltd. (Roche)
- Abbott Laboratories
- Danaher Corporation (including its subsidiary Cepheid)
- bioMérieux SA
- Thermo Fisher Scientific Company Profile
- Siemens Healthineers AG
- Becton, Dickinson and Company (BD)
- Hologic Inc.
- QIAGEN N.V.
- Grifols S.A.
- DiaSorin S.p.A.
- Seegene Inc.
- Bio‑Rad Laboratories Inc.
- Quest Diagnostics Incorporated
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible